renal osteodystrophy
Showing 26 - 50 of 8,371
REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)
Recruiting
- Cardiogenic Shock
- +2 more
- standard of care
-
Pessac, FranceBordeaux University Hospital
Mar 27, 2023
Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))
Active, not recruiting
- Kidney Neoplasms
- multiparametric and fat-detection magnetic resonance imaging (MRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1
Recruiting
- Carcinoma, Renal Cell
- Kidney Neoplasms
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital Zhejiang University School of Med
Mar 27, 2023
Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)
Recruiting
- Renal Cancer
- Magnetic Resonance Imaging (MRI) Scan
- Tc-99m Pentetate
-
New York, New YorkNYU Langone Health
Oct 31, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 28, 2023
Kidney; Mobile Trial in Tekirdag (Changing mechanic ventilatation parameters)
Recruiting
- Kidney; Mobile
- Changing mechanic ventilatation parameters
-
Tekirdag, Please Select:, TurkeyCagri Dogan
Mar 30, 2023
Renal Stone, Kidney; Complications, Ureter Stone Trial (NIRS, Taking a blood sample)
Not yet recruiting
- Renal Stone
- +3 more
- NIRS
- Taking a blood sample
- (no location specified)
Oct 31, 2023
Acute Kidney Injury Trial in Jakarta (Renal Replacement Therapy (RRT))
Recruiting
- Acute Kidney Injury
- Renal Replacement Therapy (RRT)
-
Jakarta, DKI Jakarta, IndonesiaNational Cardiovascular Center
Oct 17, 2023
The Long-term Safety and Effect of Renal Denervation
Recruiting
- Hypertension
- Renal denervation
-
London, Middlesex, United KingdomHammersmith Hospital
Apr 5, 2023
AKI - Acute Kidney Injury Trial in Alexandria (renal cell arrest and damage biomarkers assessment)
Not yet recruiting
- AKI - Acute Kidney Injury
- renal cell arrest and damage biomarkers assessment
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 26, 2023
Renal Impairment Trial in Jinan (HSK21542 Injection)
Recruiting
- Renal Impairment
- HSK21542 Injection
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Jul 12, 2023
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for
Not yet recruiting
- Kidney Tumor
- +2 more
- (no location specified)
Feb 6, 2023
Betweenq MAFLD and Chronic Kidney Disease
Not yet recruiting
- Mafld in Ckd Patients
- (no location specified)
Nov 12, 2023
Renal Impairment Trial in Chengdu (HSK16149)
Completed
- Renal Impairment
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 14, 2023
Doppler-based Renal Resistive Index in Predicting Renal Recovery
Not yet recruiting
- Acute Kidney Injury
- Doppler-based renal resistive index
- (no location specified)
May 10, 2023
Focal Segmental Glomerulosclerosis (FSGS) Trial (IXP)
Not yet recruiting
- Focal Segmental Glomerulosclerosis (FSGS)
- (no location specified)
May 9, 2023
Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Recruiting
- Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Renal Insufficiency, Acute Kidney Injury Trial in Belgrade, Sremska Kamenica (JuxtaFlow System)
Recruiting
- Renal Insufficiency
- Acute Kidney Injury
- JuxtaFlow System
-
Belgrade, Serbia
- +1 more
Aug 7, 2023
Renal Impairment, Hepatic Impairment Trial in Jinan (SIM0417 600 mg; Ritonavir100 mg, SIM0417 375 mg; Ritonavir100 mg, SIM0417
Not yet recruiting
- Renal Impairment
- Hepatic Impairment
- SIM0417 600 mg; Ritonavir100 mg
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Feb 7, 2023
Renal Colic Trial in Toulouse (CLAD-V SCORE)
Completed
- Renal Colic
- CLAD-V SCORE
-
Toulouse, Haute-Garonne, FranceCHU de Toulouse
Aug 29, 2023
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023